Approach To Care
Dr. Levine began his employment with North Memorial in 2012, and since 2016, he has served as the medical director of the North Memorial Health and CentraCare Monticello Cancer Centers. In addition to seeing customers in Robbinsdale, he is the primary hematologist/oncologist to staff the CentraCare Monticello Cancer Center.
Dr. Levine’s philosophy in healthcare is one where no single treatment approach is applicable to all customers. Because all people are special and unique, he understands that therapy must be individualized in order to yield the best possible outcomes.
He also believes in the power of education. He is active in the Broadway Family Medicine Residency Program and enjoys having physicians-in-training rotate with him in both the hospital and clinic. His passion for education extends to the clinical care setting and he hopes that after every encounter his customers have a greater understanding of their disease and the rationale for therapy.
While Dr. Levine enjoys all of the complexities of hematology and oncology and considers himself to be a general hematologist/oncologist, his specific interests are in the treatment of cancers of the liver and pancreas, the gastrointestinal tract, as well as leukemias and lymphomas.
- Medical School – University of Minnesota
- Internal Medicine Residency – Hennepin County Medical Center
- Hematology, Oncology and Stem Cell Transplantation Fellowship – University of Minnesota
- American Board of Internal Medicine
- American Board of Internal Medicine (Sub: Hematology)
- American Board of Internal Medicine (Sub: Medical Oncology)
- Minnesota Monthly’s Top Doctors: 2015, 2019-2021
- Morris Davidman Resident Teaching Award
- American Society of Clinical Oncology
- GammaTile® brachytherapy in the treatment of recurrent glioblastomas. Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022.
- Evaluation of Infusion-Related and Hypersensitivity Reactions to Chemotherapy Over a Decade at a Community Cancer Center. Sarah Maryon Hayes, PharmD, BCOP; Jeremy Whalen, PharmD, BCOP; Nick Schutz, PharmD; Joseph Levine, MD. J Hematol Oncol Pharm. 2021;11(1):30-36
- Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer. Ruud P.M. Dings, Joseph I. Levine, Susan G. Brown, Lucile Astorgues Xerri, John R. MacDonald, Thomas R. Hoye, Eric Raymond, Kevin H. Mayo; Investigational New Drugs. Feb. 2013
- American Society of Clinical Oncology
During his fellowship, Dr. Levine worked in the departments of chemistry and biochemistry at the University of Minnesota where his project focused on the development of a series of novel molecules for the treatment of cancer. The synthetic strategies of these compounds, in addition to their potent anti-cancer properties, have been published in peer-reviewed journals. Shortly after he completed his fellowship training, these compounds were patented.
Exercise has always been an important part of Dr. Levine’s life. He enjoys swimming, running, downhill skiing, weightlifting, and makes boxing a part of his morning routine. He believes that exercise is an important component of health maintenance as well as in the management of disease. When he isn’t working, he spends the majority of his free time at home with his wife and children and goldendoodle, Yoshi.
All North Memorial Health providers accept the following insurance carriers. Because health insurance plan payments vary and benefit levels are unique to each plan, you may confirm out of pocket cost with your insurance carrier by calling the number on the back of your insurance card.
- Blue Cross
- Medical Assistance
- Preferred One